drugset / Trial / NCT00793026

Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability

NCT00793026 ↗

Phase 3 Completed 30 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Timeline

Start
2008-11
Primary completion
2008-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dermacyd Breeze Pocket BR (Lactic Acid) Unknown — —

Indications

No indication recorded.